Dr. Luggen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3590 Lucille Dr
Cincinnati, OH 45213Phone+1 513-458-1600Fax+1 513-458-1984- Is this information wrong?
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Allergy and Immunology, 1980 - 1982- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1974 - 1977
Columbia University Vagelos College of Physicians and SurgeonsClass of 1974
Certifications & Licensure
OH State Medical License 1977 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
- Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
Publications & Presentations
PubMed
- 6 citationsOlokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necro...Eugen Feist, Saeed Fatenejad, Sergey Grishin, Elena Korneva, Michael E Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S Smolen, Roy M Fleischmann> ;Annals of the Rheumatic Diseases. 2022 Dec 1
- 5 citationsDepression-, Pain-, and Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus.Nathalie E Chalhoub, Michael E Luggen> ;International Journal of Rheumatology. 2022 Jan 1
- 35 citationsEfficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week pha...Philip J. Mease, Saima Chohan, Ferran J Garcia Fructuoso, Michael E. Luggen, Proton Rahman, Siba P. Raychaudhuri, Richard C Chou, Alan M. Mendelsohn, Stephen J. Rozzo,...> ;Annals of the Rheumatic Diseases. 2021 May 13
- Join now to see all
Press Mentions
R-pharm’s Rheumatoid Arthritis Drug, Olokizumab, Offers Significant Benefits in Phase 3 CREDO TrialMay 20th, 2021
Grant Support
- Sulfasalazine In The Treatment Of Ankylosing SpondylitisNational Center For Research Resources1990
- Early Undifferentiated Connective Tissue DiseaseNational Center For Research Resources1990
Professional Memberships
- Fellow
Hospital Affiliations
University of Cincinnati Medical CenterCincinnati, Ohio
Cincinnati Veterans Affairs Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
